Group 1 - The top three companies with the highest AH premium rates are Northeast Electric (00042) at 831.03%, Zhejiang Shibao (01057) at 339.32%, and Sinopec Oilfield Service (01033) at 323.71% [1][2] - The bottom three companies with the lowest AH premium rates are CATL (03750) at -14.62%, China Merchants Bank (03968) at -3.22%, and Hengrui Medicine (01276) at 1.77% [1][2] - Sinopec Oilfield Service (01033), Andeli Juice (02218), and Shandong Molong (00568) have the highest deviation values at 53.41%, 21.68%, and 19.01% respectively [1][2] Group 2 - The companies with the lowest deviation values include Zhejiang Shibao (01057) at -58.91%, Yangtze Optical Fibre and Cable (06869) at -49.00%, and Fudan Zhangjiang (01349) at -24.81% [1][2][4] - The top ten AH stocks by premium rate include companies like Hongye Futures (03678) and Beijing Electromechanical (00187) with premium rates of 258.91% and 257.99% respectively [2] - The bottom ten AH stocks by premium rate include Weichai Power (02338) and Midea Group (00300) with premium rates of 6.84% and 8.51% respectively [2]

进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为392.77万元。该股近5个交易日累 计上涨3.17%，主力资金合计净流入1772.21万元。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 1月29日，康希诺收跌3.64%，收盘价为69.69元，发生1笔大宗交易，合计成交量6.39万股，成交金额 392.77万元。 第1笔成交价格为61.47元，成交6.39万股，成交金额392.77万元，溢价率为-11.80%，买方营业部为中国 银河证券股份有限公司北京金融街证券营业部，卖方营业部为华泰证券股份有限公司北京月坛南街证券 营业部。 责任编辑：小浪快报 ...

Core Viewpoint - The company expects to achieve an annual revenue of 1.04 billion to 1.08 billion yuan in 2025, representing a year-on-year growth of 22.88% to 27.61% [1] - The company anticipates a net profit attributable to shareholders of 24.5 million to 29 million yuan for the same period, indicating a turnaround from previous losses [1] Financial Performance - The company is focused on innovation and commercialization, with its first quadrivalent meningococcal vaccine, Manhaixin®, showing continuous revenue growth [1] - Cost reduction and efficiency improvement measures have been effectively implemented, leading to better expense management [1] - The optimization of production and sales coordination has resulted in an increase in gross profit margin, significantly enhancing overall profitability [1]

Core Viewpoint - The report highlights the AH premium rates of various stocks, indicating significant disparities between H-shares and A-shares, with some stocks showing extremely high premiums while others exhibit negative premiums [1][2]. Group 1: Top AH Premium Rates - Northeast Electric (00042) leads with an AH premium rate of 847.37%, followed by Zhejiang Shibao (01057) at 349.31% and Beijing Jingcheng Machinery Electric (00187) at 279.42% [1][2]. - The lowest AH premium rates are recorded for Contemporary Amperex Technology (03750) at -14.34%, China Merchants Bank (03968) at -4.99%, and Heng Rui Medicine (01276) at -1.15% [1][2]. Group 2: Top AH Deviation Values - Junshi Biosciences (01877) has the highest deviation value at 22.43%, followed closely by Beijing Jingcheng Machinery Electric (00187) at 22.18% and CanSino Biologics (06185) at 21.90% [1][3]. - The lowest deviation values are observed in Changfei Optical Fiber (06869) at -50.58%, Zhejiang Shibao (01057) at -45.38%, and Nanhua Futures (02691) at -27.12% [1][4]. Group 3: Detailed AH Premium and Deviation Rankings - The top ten AH stocks by premium rate include companies like Hongye Futures (03678) with a premium of 271.30% and Sinopec Oilfield Service (01033) at 248.51% [2]. - The bottom ten AH stocks by premium rate include WuXi AppTec (02359) with a slight premium of 0.42% and Midea Group (00300) at 6.75% [2]. - The top ten stocks by deviation also feature companies like Goldwind (02208) at 19.35% and Andeli Juice (02218) at 19.04% [3].

报告期内，公司持续践行以创新为核心、以商业化落地为重点的发展战略，中国首款四价流脑结合疫苗 曼海欣 收入保持持续增长。同时，公司深入推进降本增效，各项费用得到有效管控；产销协同进一步 优化，毛利率亦有所提升。整体盈利能力显著提升，成功于报告期实现归属于母公司所有者的 近日，康希诺发布公告称，经公司财务部门初步测算，预计2025年年度实现营业收入10.4亿元到10.8亿 元，同比增长22.88%到27.61%。预计2025年年度实现归属于母公司所有者的净利润为2450万元到2900 万元，与上年同期相比，将实现扭亏为盈。 ...

政府統計處發表的對外商品貿易統計數字顯示，2025 年 12 月份本港整體出口 和進口貨值均錄得按年升幅，分別上升 26.1%和 30.6%。市場預期分別上升 16.8% 及 19.9% 港股點評 2026年1月28日9:30 a.m 恒指升 361 點，滬指升 7 點，標普 500 升 28 點 外圍股市上升。港股造好。恒指高開 97 點後升幅擴大，曾升 423 點一度高見 27,188 點，全日升 361 點或 1.4%，收 27,126 點；國指升 97 點或 1.1%，收 9,244 點；恒生科指升 28 點或 0.5%，收 5,754 點。大市全日成交總額 2,543.73 億元。 人民幣兌美元中間價按日下調 15 點，報 6,9858 兌一美元。人民銀行 27 日在公 開市場開展 4,020 億元人民幣七天期逆回購操作，操作利率持平於 1.4%。有 3,240 億元逆回購到期，單日淨投放 780 億元。A 股三大指數早市個別發展，午後全 線穩升。滬綜指全日收升 7 點或 0.2%，報 4,139 點，成交 1.29 萬億元。深成指 全日收升 13 點或 0.09%，報 14,329 點，成交 1. ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日。 （二）业绩预告情况 1、经康希诺生物股份公司（以下简称"公司"）财务部门初步测算，预计2025年年度（以下简称"报告 期"）实现营业收入104,000.00万元到108,000.00万元，与上年同期相比，将增加19,366.19万元到 23,366.19万元，同比增长22.88%到27.61%。 2、预计2025年年度实现归属于母公司所有者的净利润为2,450.00万元到2,900.00万元，与上年同期相 比，将实现扭亏为盈。 3、预计2025年年度实现归属于母公司所有者扣除非经常性损益后净利润为-9,100.00万元到-9,600.00万 元。 （三）本次业绩预告未经注册会计师审计。 二、上年同期业绩情况 公司2024年年度实现营业收入为84,633.81万元，利润总额为-38,120.45万元，归属于母公司所有者的净 利润为-37,888.40万元，归属于母公司所有者扣除非经常性损益后 ...

| જેટ મેતિ | 公司 | 主要内容 | | --- | --- | --- | | 聚焦 | 臺韋点 | 筹划控制权变更事项 28日起停牌 | | | 万科A | 深铁集团向公司提供不超过23.6亿元借款 | | | 东材科技 | 实控人、副董事长熊海涛被留置 | | | 国泰海通等 | 业绩预增 | | | 多家券商 | | | | 康希诺 | 预计2025年净利润2450万元-2900万元 同比 扭亏为盈 | | | 何氏眼科 | 2025年度预盈2400万至3600万元 同比扭亏 | | | 常山北明 | 2025年度预盈3500万元 同比扭亏 | | | 国盾量子 | 预计2025年净利润500万元左右 同比扭亏为盈 | | | 宁波富邦 | 2025年净利润同比预增3099.59%-4379.43% | | | 金马游乐 | 2025年净利润同比预增811.17%-1069.56% | | | 怡球资源 | 2025年净利润同比预增620%-970% | | | 臻雷科技 | 2025年净利润同比预增530%-642% | | 业绩精选 | 英图川醋 | 2025年净利润同比预增428.3 ...

Core Viewpoint - Several companies are expected to turn profitable by 2025, with projected net profits indicating a significant recovery from previous losses [1] Group 1: Company Projections - Saiwei Electronics is projected to achieve a net profit of 1.414 billion to 1.504 billion yuan in 2025, marking a turnaround from losses [1] - Ganfeng Lithium anticipates a net profit of 1.1 billion to 1.65 billion yuan in 2025, also indicating a return to profitability [1] - Buchang Pharma expects a net profit ranging from 320 million to 468 million yuan in 2025, reflecting a recovery [1] - Zhiguang Electric forecasts a net profit of 110 million to 160 million yuan in 2025, showing a positive shift [1] - Zhong Rare Metals predicts a net profit of 100 million to 130 million yuan in 2025, indicating a turnaround [1] - Jingwei Hengrun expects a net profit of 75 million to 110 million yuan in 2025, marking a return to profit [1] - Tongguan Copper Foil anticipates a net profit of 55 million to 75 million yuan in 2025, indicating a recovery [1] - Weijie Chuangxin projects a net profit of 45 million yuan in 2025, reflecting a positive change [1] - Changshan Beiming expects a net profit of 35 million yuan in 2025, indicating a turnaround [1] - CanSino Biologics anticipates a net profit of 24.5 million to 29 million yuan in 2025, marking a return to profitability [1] - Gaolan Co. projects a net profit of 23.5 million to 30.5 million yuan in 2025, indicating a recovery [1] - Shenkeda expects a net profit of 20 million to 29 million yuan in 2025, reflecting a positive shift [1] - Guodun Quantum anticipates a net profit of 5 million yuan in 2025, indicating a turnaround [1]

北京商报讯（记者 丁宁）1月27日晚间，康希诺（688185）发布2025年业绩预告显示，预计2025年实现 归属净利润为2450万元到2900万元，与上年同期相比，将实现扭亏为盈。 康希诺表示，报告期内，公司持续践行以创新为核心、以商业化落地为重点的发展战略，中国首款四价 流脑结合疫苗曼海欣收入保持持续增长。同时，公司深入推进降本增效，各项费用得到有效管控；产销 协同进一步优化，毛利率亦有所提升。整体盈利能力显著提升，成功于报告期实现归属净利润为正。同 时，报告期内，随着公司研发项目的快速推进及国际合作的开展，公司获得了更多政府专项补助及国际 专项资金的支持，故于报告期产生较大金额的非经常性收益。 ...